WHAMglobal’s Post

Canada's federal government has announced a groundbreaking initiative in Budget 2024 to make contraception and diabetes medications free for Canadians. This significant move aims to alleviate the financial burden of essential medications, promoting better health and ensuring that all Canadians have access to necessary treatments. #affordablehealthcareCanada #Canadianhealthcarebudget #contraceptioncoverageCanada #diabetestreatmentCanada #federalhealthfunding #freecontraception #freediabetesmedications #healthcareaccessibilityCanada #nationalpharmacareinitiative #universalpharmacareplan

In honor of Women's Health Month, we're highlighting pharmacists' pivotal role in supporting women. From providing counseling on contraception to managing menopause symptoms, you can equip women with the education and resources needed to maintain their health. Learn other ways you can make a difference. #pharmacy #pharmacist #pharmacistrole #womenshealth #SingleCare #womenshealthmonth

I'm thrilled to announce that I will present three posters at the upcoming ISPOR 2024 conference in Atlanta from May 8-10. 📊 I will present three posters "Comparative Cost-Effectiveness of Interventions for Perinatal Methamphetamine Use Disorder" - Exploring Transcranial magnetic stimulation (TMS) as a solution for Methamphetamine use disorders in pregnant women. "Barriers and Provision of Emergency and Pharmacist-Prescribed Contraception" - Highlighting crucial insights from pharmacy practices in Utah. "Risk of Gastrointestinal (GI) Bleeding for Aspirin Users" - A comprehensive review to predict the risk of GI bleeding with low-dose aspirin Looking forward to connecting with peers, exploring groundbreaking research, and contributing to our understanding of these critical issues. Let's make a difference together! 🚀 #ISPOR2024 #HealthEconomics #OutcomesResearch #PublicHealth #Pharmacotherapy

Please join us Monday for this important conversation about all the ways you can directly access contraception at pharmacies and how to increase public awareness about OTC and direct pharmacist prescribed options. Help us spread the word!

"Using these recommendations, providers can reduce unnecessary barriers to contraception access and use." For Contemporary OB/GYN, Celeste Krewson looks at the CDC's updated contraception guidelines on topics like addressing IUD insertion pain, bleeding irregularities with implant use, testosterone use and the risk for pregnancy, and self-administration of injectables. With user-centered care core to many of these recommendations, it's easy to see a link to user-centered design and development. #Contraception #Contraceptive #FamilyPlanning #FP #SexualAndReproductiveHealth #SRH #SexualAndReproductiveHealthAndRights #SRHR https://lnkd.in/gmFN2nPn

The focus on women's health continues to drive important conversations. One hot topic is the pain and discomfort associated with IUD insertion. Recent decisions from a Planned Parenthood location in the US have made headlines that continue to keep this topic top-of-mind.  https://lnkd.in/g2q_B_MW Our Canadian OBGyns are committed to advancing contraception offerings in Canada and continue to focus on best options and how to improve the experience moving forward. We look forward to a future where IUD insertion becomes more manageable for Canadian patients. #womenshealth #contraception #IUD #IUDpainmanagement #beinformed #newIUDoptions #IUDinnovations #IUDpain #IUDprogress 

Survey Shows HCPs Are Preferred Source For Contraceptive Information Among AYAs: The survey demonstrated that adolescents and young adults (AYAs) who preferred health care professionals (HCPs) as sources of information had sufficient knowledge of contraception options available. #finance #pharmacy #lifesciences

On January 28th, CRHLP hosted the webinar "Strategies for Increasing Public Awareness of Over-the-Counter and Pharmacist-Prescribed Contraception." If you missed the webinar, or just want to rewatch the conversation, a link to watch is available here: https://lnkd.in/dzA9Tydr This moderated discussion framed the challenges to expanding contraceptive access, shared successes from pharmacists and partners, and identified opportunities on the horizon to increase demand for contraceptive services at pharmacies. The webinar covered pharmacist-prescribed contraception and the goal of increasing awareness of Opill, which is now available at pharmacies over the counter. We aim to empower movement partners by highlighting pharmacist prescribing as an important component of a broader "pharmacy-first" approach to contraception access. Watch the recording here: https://lnkd.in/dzA9Tydr, read our new policy brief aimed at increasing access to contraception by expanding the role of pharmacists here: https://lnkd.in/gqw2jaV9, and register now for the second webinar in this series, Insurance and Medicaid Coverage, Reimbursement, and Billing for Pharmacist-Prescribed Contraception happening on March 3rd at 12 PM PT: https://lnkd.in/dBq6y89y

𝗗𝗮𝘁𝗲 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿 𝗱𝗶𝗮𝗿𝘆: 𝗡𝗛𝗦 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝘆 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝗲𝗽𝘁𝗶𝗼𝗻 𝗦𝗲𝗿𝘃𝗶𝗰𝗲 (𝗣𝗖𝗦) - 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝗶𝗻𝗴 𝗵𝗶𝗴𝗵 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝘁𝗶𝗼𝗻𝘀 𝗗𝗮𝘁𝗲 𝗮𝗻𝗱 𝘁𝗶𝗺𝗲: 𝗧𝘂𝗲𝘀𝗱𝗮𝘆 𝟰𝘁𝗵 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝟮𝟬𝟮𝟱 𝗳𝗿𝗼𝗺 𝟳-𝟵𝗽𝗺 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: 𝗞𝗲𝗴𝘄𝗼𝗿𝘁𝗵 𝗛𝗼𝘁𝗲𝗹 𝗮𝗻𝗱 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗖𝗲𝗻𝘁𝗿𝗲, 𝗣𝗮𝗰𝗸𝗶𝗻𝗴𝘁𝗼𝗻 𝗛𝗶𝗹𝗹, 𝗞𝗲𝗴𝘄𝗼𝗿𝘁𝗵, 𝗗𝗘𝟳𝟰 𝟮𝗗𝗙 CPPE, Community Pharmacy Derbyshire and Community Pharmacy Nottinghamshire have teamed up to host this collaborative workshop for contractors and their teams. The Community Pharmacy England website reminds us that the 31st March 2025 is the deadline for pharmacy owners who are delivering Pharmacy First to also deliver the Pharmacy Contraception Service and Hypertension Case-Finding Service to qualify for the monthly £1,000 fixed payment (as well as meeting the relevant consultation threshold). This is a great opportunity for those who are not yet signed up to this service to get trained and signed up to the service by the end of March. 𝗧𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝗶𝘀 𝗹𝗶𝗺𝗶𝘁𝗲𝗱 𝘁𝗼 𝟰𝟮 𝗽𝗹𝗮𝗰𝗲𝘀 𝘀𝗼 𝗲𝗮𝗿𝗹𝘆 𝗯𝗼𝗼𝗸𝗶𝗻𝗴 𝗶𝘀 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹. Emma Anderson, Regional CPPE Tutor, says: "As well as working for CPPE, I am a jobbing community pharmacist, so I know how busy and pressured things are now. Therefore, we have designed the learning to make the most of the time that you have available. Preparation tasks are based on a self-assessment of your needs. Following the workshop there is an option to attend a support webinar with Kirsty Armstrong who leads the service for NHS England and Alastair Buxton of Community Pharmacy England. Two other community pharmacists and I who deliver the service will also be there to answer questions. The workshop part of this learning will be hosted by Penny Mosley, and I will be attending as speaker for the event". You can book the workshop here 👇🏻 https://lnkd.in/eu6hNA2N You will also find a link to book the post workshop support webinar in that page. 𝗣𝗹𝗲𝗮𝘀𝗲 𝗻𝗼𝘁𝗲: 𝘆𝗼𝘂 𝘄𝗶𝗹𝗹 𝗻𝗲𝗲𝗱 𝗮 𝗸𝗲𝘆𝗰𝗼𝗱𝗲 𝗳𝗼𝗿 𝘁𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝘀𝗼 𝗲𝗺𝗮𝗶𝗹 𝗳𝗿𝗼𝗺 𝘆𝗼𝘂𝗿 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝘆 𝗡𝗛𝗦 𝗺𝗮𝗶𝗹 𝘁𝗼 𝗶𝗻𝗳𝗼@𝗰𝗽𝗻𝗼𝘁𝘁𝘀.𝗼𝗿𝗴 𝗮𝗻𝗱 𝘁𝗵𝗶𝘀 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗳𝗼𝗿𝘄𝗮𝗿𝗱𝗲𝗱 𝘁𝗼 𝘆𝗼𝘂. #pharmacyservices #pharmacycontraceptionservice #pharmacyfirst #training

DEVELOPMENT AND BARRIERS IN THE IMPLEMENTATION OF MORNING AFTER PILL SUPPLIES IN THE EUROPEAN UNION Dear Stakeholders in the EU and UK, We kindly invite you to answer a few questions regarding the public provision of morning after pill levonorgestrel 1500mcg and ulipristal acetate 30mg in your country. The pharmacy profession around the world is facing a lot of systematic changes in pharmacy practices, and we are considering possible best practices from other countries. This survey will take only 5 minutes and is about answering the supply schemes of emergency hormonal contraception service delivered in EU and United Kingdom. This survey has been designed by EPhEU Employed community Pharmacists and your participation is entirely voluntary. Accepting the survey will be considered as consent to participate in the study. All information we collect will be kept strictly confidential. They will not be shared with anyone outside of our research team. By publishing or presenting the results of this study, we will not disclose any information from which you could be identified. All survey data will be stored in a locked cabinet and on a password-protected computer. After the end of the study, the data will be kept for 7 years from the last publication of the study. Then the data will be destroyed. You may not directly benefit from participating in the study. Nevertheless, your input and point of view are of great value to us. Completing the survey is considered your consent to participate in the survey. If you have any questions, please contact: Dr Piotr Merks - project coordinator phone number: +48 602 101 979, e-mail: p.merks@uksw.edu.pl We greatly appreciate your help in this study. Thank you for your time and attention and your contribution. Link: https://lnkd.in/dTcRSbmc